What is a LIMA (Left Internal Mammary Artery) in the context of coronary artery bypass grafting (CABG) surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a LIMA (Left Internal Mammary Artery)?

The Left Internal Mammary Artery (LIMA) is the gold standard blood vessel conduit used in coronary artery bypass grafting (CABG) surgery, primarily to bypass blockages in the Left Anterior Descending (LAD) artery, with superior long-term patency rates exceeding 90% at 10-15 years. 1, 2

Anatomical Location

  • The LIMA is located in the anterior mediastinum, positioned anterior to the pericardium and heart, making it readily accessible during median sternotomy for cardiac surgery 1
  • It is harvested either as a pedicled graft (with surrounding tissue) or as a skeletonized graft (vessel alone), then brought down to reach the heart surface for anastomosis to the LAD 1

Why LIMA is the Gold Standard

  • LIMA-to-LAD grafting is a Class I recommendation (Level of Evidence: B) in coronary artery bypass surgery 1
  • The LIMA demonstrates >90% patency at 10-15 years, vastly superior to saphenous vein grafts which show only 50-60% patency at 10 years 1, 2
  • Use of LIMA significantly reduces mortality, recurrent myocardial infarction, rehospitalization for cardiac events, and need for repeat revascularization compared to other conduits 1

Clinical Indications for LIMA Use

  • Patients with diabetes and multivessel disease including hemodynamically significant LAD disease should receive CABG with LIMA-to-LAD over percutaneous coronary intervention (PCI) 1
  • Patients with complex 3-vessel coronary artery disease (especially with SYNTAX score >22) benefit from CABG with LIMA-to-LAD over PCI 1
  • Patients with left main disease have particularly strong evidence supporting CABG with LIMA-to-LAD 1
  • For redo CABG procedures, LIMA is the conduit of choice in patients who did not receive LIMA previously 1

Critical Technical Considerations

  • The LIMA should only be used to bypass vessels with adequate stenosis severity—at least 70% for left-sided vessels including the LAD—to avoid competitive flow-related graft failure 3
  • Arterial grafts like LIMA are muscular conduits that respond to low-flow states with vasospasm and eventual atrophy when competitive flow exists 3
  • Large LIMA side branches should be ligated during surgery to prevent coronary steal phenomenon, which can cause postoperative angina 4

Contraindications and When Not to Use LIMA

  • Significant proximal left subclavian stenosis is an absolute contraindication to LIMA use, as it would compromise flow through the graft 1
  • When LIMA is unavailable or unsuitable, the right internal mammary artery (RIMA) is the recommended alternative for LAD bypass 1

Quality Measure

  • The American College of Cardiology/American Heart Association measures the percentage of eligible patients who receive an internal mammary artery graft (preferably LIMA) when bypass of the LAD is indicated as a quality control metric 1, 5
  • LIMA usage rates of >90% are considered the benchmark for quality CABG programs 5

References

Guideline

Use of LIMA in Coronary Artery Bypass Grafting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Preferred Vein Sources for CABG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Arterial Grafts and Competitive Flow in CABG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is a LIMA (Left Internal Mammary Artery) in the context of coronary artery bypass grafting (CABG) surgery?
What are LIMA (Left Internal Mammary Artery) and LAD (Left Anterior Descending artery)?
Why is the Left Internal Mammary Artery (LIMA) resistant to atherosclerosis?
What is a Lima (Left Internal Mammary Artery) graft?
What is the patency rate of the Left Internal Mammary Artery (LIMA) graft after Coronary Artery Bypass Grafting (CABG) in patients with Pseudoxanthoma Elasticum (PXE)?
Can a patient with a history of pulmonary embolism (PE) who had transiently elevated Brain Natriuretic Peptide (BNP) and High Sensitivity Troponin I (hs-TnI) levels, which later normalized, have had acute right ventricular strain or failure that resolved, and is it possible for them to have incurred permanent damage to the heart and lung?
How is the dose of Synthroid (levothyroxine) adjusted when converting from oral to intravenous (IV) administration?
What is the best course of treatment for a patient with sinus bradycardia, supraventricular tachycardia (SVT), and rare ventricular ectopic beats (VE), with a maximum heart rate of tachycardia and a minimum heart rate of bradycardia, who is asymptomatic and possibly taking medications such as beta blockers?
Does a patient with a 15-year history of erectile dysfunction, characterized by erections not lasting long enough, who experiences nocturnal erections, has hypertension and hyperlipidemia, but no other significant medical history, meet the criteria for treatment with sildenafil?
What is the best treatment approach for an adult patient presenting with vertigo and no significant medical history?
What is the treatment plan for a patient with Immune Thrombocytopenic Purpura (ITP) who has had an insufficient response to corticosteroids or immunoglobulins, considering romiplostim (Nplate) as a treatment option?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.